Select Agents | Global Biodefense

Menu

Latest stories

Cutting Edge Chemical and Biological Defense Science: Hot Topics at CBD S&T 2019

Why Do We Need a New Smallpox Vaccine?

More on pathogens and preparedness

BioFactura’s Smallpox Biodefense Therapeutic Awarded $67M BARDA Contract

by Global Biodefense September 26, 2019, 8:58 am
FDA Approves Jynneos to Prevent Smallpox and Monkeypox

by Global Biodefense September 24, 2019, 8:00 pm
Biosafety Levels in Laboratories – What is the Difference?
DoD Inspector General to Reevaluate Select Agent Facilities, Biosafety Oversight

by Stephanie Lizotte September 9, 2019, 3:23 pm
Biodefense World Summit 2019

by Global Biodefense June 17, 2019, 12:00 am
Crimean Congo Countermeasures: Researchers Investigate CCHFV-RDRp

by Global Biodefense June 11, 2019, 5:00 am
Researchers Optimize Novel Hexaplex PCR Assay for Simultaneous Detection of Anthrax and Plague Pathogens
Popular

Ebola Situation Worsening and Still Only Half of Response Budget is Funded

by Global Biodefense May 1, 2019, 5:55 am
Ology Bioservices Awarded DoD Contract for Countermeasures Against Bioweapons

by Global Biodefense April 15, 2019, 8:16 am
2019 ASM Biothreats

by Global Biodefense January 29, 2019, 12:00 am
NICBR Winter Symposium on Novel Therapeutics
BARDA Looks to Expand Clinical Studies Network for Biodefense Countermeasures

by Global Biodefense January 14, 2019, 8:00 am

Congratulations. You've reached the end of the internet.

Back to Top